Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference
Get Alerts DGX Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.5%
EPS Growth %: +10.0%
Join SI Premium – FREE
The fireside chat and Q&A session will be webcast live during the conference on the company's investor relations page, which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-baird-2026-global-healthcare-conference-302857720.html
SOURCE Quest Diagnostics
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2026 IMS | IASO Bio Presented FUCASO China Real-World Data
- 2026 IMS | IASO Bio Presented First-in-Human Data of BCMA-Targeted In Vivo CAR-T Cell Therapy IASO206
- BNB vs Remittix: Can Binance Coin Clear $800 Before RTX Reaches Its $0.46 Final Presale Stage?
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share